These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22935797)

  • 21. Fighting fat. New drugs against obesity in the pipeline.
    Brower V
    EMBO Rep; 2002 Jul; 3(7):601-3. PubMed ID: 12101089
    [No Abstract]   [Full Text] [Related]  

  • 22. Slim spoils for obesity drugs.
    Ledford H
    Nature; 2010 Dec; 468(7326):878. PubMed ID: 21164452
    [No Abstract]   [Full Text] [Related]  

  • 23. Suspense builds on anti-obesity rollercoaster ride.
    Jones D
    Nat Rev Drug Discov; 2011 Jan; 10(1):5-6. PubMed ID: 21193855
    [No Abstract]   [Full Text] [Related]  

  • 24. What is the long-term efficacy and tolerability of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity in primary care?
    Leiser JP; Gunning K
    J Fam Pract; 2000 Jun; 49(6):572-3. PubMed ID: 10923560
    [No Abstract]   [Full Text] [Related]  

  • 25. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
    Correia ML; Haynes WG
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promises kept and broken: new pharmaceuticals.
    Malik P
    Can J Cardiol; 2002 May; 18(5):493-4. PubMed ID: 12032574
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA seeks advice on track-and-trace systems.
    Traynor K
    Am J Health Syst Pharm; 2011 Apr; 68(7):552-4. PubMed ID: 21411794
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug therapy of obesity will come later].
    Falkenberg M
    Lakartidningen; 1999 May; 96(21):2582-3. PubMed ID: 10388276
    [No Abstract]   [Full Text] [Related]  

  • 29. Pediatric research: coming of age in the new millennium.
    Milne CP
    Am J Ther; 1999 Sep; 6(5):263-82. PubMed ID: 11329108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National trends in the use and costs of anti-obesity medications in England 1998-2005.
    Srishanmuganathan J; Patel H; Car J; Majeed A
    J Public Health (Oxf); 2007 Jun; 29(2):199-202. PubMed ID: 17494061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In search of fat profits.
    Watts G
    BMJ; 2007 Jun; 334(7607):1298-9. PubMed ID: 17585156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical interventions for obesity: a public health perspective.
    Caveney E; Caveney BJ; Somaratne R; Turner JR; Gourgiotis L
    Diabetes Obes Metab; 2011 Jun; 13(6):490-7. PubMed ID: 21205125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What's so great about newness?
    Light DW
    Health Aff (Millwood); 2007; 26(6):1793; author reply 1793-4. PubMed ID: 17978409
    [No Abstract]   [Full Text] [Related]  

  • 34. Repairing the broken market for antibiotic innovation.
    Outterson K; Powers JH; Daniel GW; McClellan MB
    Health Aff (Millwood); 2015 Feb; 34(2):277-85. PubMed ID: 25646108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diet-drug dilemma.
    Blackburn G
    Health News; 1999 Jun; 5(7):2. PubMed ID: 10932774
    [No Abstract]   [Full Text] [Related]  

  • 36. Out of sight. Pharmaceutical industry temporarily replaces hospitals as target.
    McLaughlin N
    Mod Healthc; 2004 Oct; 34(42):26. PubMed ID: 15552190
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA embraces RFID to protect drug supply.
    Young D
    Am J Health Syst Pharm; 2004 Dec; 61(24):2612, 2615. PubMed ID: 15646694
    [No Abstract]   [Full Text] [Related]  

  • 38. Are newer drugs better drugs?
    Andersen T
    Obes Rev; 2003 May; 4(2):75. PubMed ID: 12760440
    [No Abstract]   [Full Text] [Related]  

  • 39. [Conference 1. An economic observatory for orphan drugs: myth or reality?].
    Duguet C; Ferry A
    Med Sci (Paris); 2014 Apr; 30 Spe(1):21-3. PubMed ID: 24755173
    [No Abstract]   [Full Text] [Related]  

  • 40. The Osler Lecture 2012: 'pharmacology 2.0, medicines, drugs and human enhancement'.
    Flower R
    QJM; 2012 Sep; 105(9):823-30. PubMed ID: 22723455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.